Compared with some other anti-obesity medications taken over similar durations, including semaglutide, tirzepatide showed stronger decreases in body-fat compartments
Triple Agonists (GLP-1 + GIP + Glucagon): Retatrutide, developed by Eli Lilly, takes the logic a step further by adding a glucagon receptor target
Incluso, desde octubre del 2022 varias farmacias en Espaa y en otros pases reportaron la escases del frmaco Ozempic debido a la alta demanda
Now take a patient who starts at 185 pounds and stays at a lower dose due to mild nausea
Maintain a consistent room temperature, avoiding exposure to direct sunlight, heat, or moisture as these can degrade the medication
I also realized that it's okay to look for answers outside of the standard health system